World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
130
Citations
70151
World Ranking
2476
National Ranking
1396

Overview

Stephen D. Silberstein is affiliated with Thomas Jefferson University in the United States. Their research primarily focuses on medicine, with significant contributions in psychiatry and mental health, pathology and forensic medicine, neurology, physiology, and molecular biology.

Silberstein's work spans several main topics including:

  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Ophthalmology and Eye Disorders
  • Psychosomatic Disorders and Their Treatments
  • Cerebral Venous Sinus Thrombosis

Their recent publications cover significant migraine research, including:

  • Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review, 2020, Headache The Journal of Head and Face Pain
  • Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial, 2021, European Journal of Neurology
  • Long-term safety, tolerability, and efficacy of fremanezumab in migraine, 2020, Neurology
  • Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency, 2021, Headache The Journal of Head and Face Pain
  • Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine, 2021, Journal of the American College of Cardiology

Frequent coauthors in Silberstein's research include:

  • David W. Dodick
  • Richard B. Lipton
  • Peter J. Goadsby
  • Hsiangkuo Yuan
  • Joshua M. Cohen

Silberstein has published extensively in a few key journals, including:

  • Neurology (18 publications)
  • Headache The Journal of Head and Face Pain (13 publications)
  • Pain and Therapy (3 publications)
  • European Journal of Neurology (2 publications)
  • Journal of the American College of Cardiology (2 publications)

Their research contributions span a broad range of neurological and headache-related conditions, with an emphasis on clinical studies of migraine mechanisms, preventive treatments, and associated neurological disorders.

Best Publications

  • The International Classification of Headache Disorders, 3rd edition (beta version)

    Jes Olesen;André Bes;Robert Kunkel;James W. Lance

  • Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology

    Stephen D. Silberstein

  • OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

    HC Diener;DW Dodick;SK Aurora;CC Turkel

  • New Appendix Criteria Open for a Broader Concept of Chronic Migraine

    J. Olesen;M -G Bousser;H -C Diener;D. Dodick

  • OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora

  • Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

    S.D. Silberstein;S. Holland;F. Freitag;D.W. Dodick

  • Fremanezumab for the Preventive Treatment of Chronic Migraine

    Stephen D. Silberstein;David W. Dodick;Marcelo E. Bigal;Paul P. Yeung

  • Classification of daily and near-daily headaches: Field trial of revised IHS criteria

    Stephen D. Silberstein;Richard B. Lipton;Martin John Sliwinski

  • Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    Stewart Tepper;Messoud Ashina;Uwe Reuter;Jan L Brandes

  • Botulinum Toxin Type A as a Migraine Preventive Treatment

    Stephen Silberstein;Ninan Mathew;Joel Saper;Stephen Jenkins

  • Premonitory symptoms in migraine: an electronic diary study.

    N. J. Giffin;L. Ruggiero;R. B. Lipton;S. D. Silberstein

  • Topiramate in Migraine Prevention: Results of a Large Controlled Trial

    Stephen D. Silberstein;Walter Neto;Jennifer Schmitt;David Jacobs

  • Classification of Daily and Near‐Daily Headaches: Proposed Revisions to the IHS Criteria

    Stephen D. Silberstein;Richard B. Lipton;Seymour Solomon;Ninan T. Mathew

  • Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

    Stephen D. Silberstein;Richard B. Lipton;David W. Dodick;Frederick G. Freitag

  • Cutaneous allodynia in the migraine population.

    Richard B. Lipton;Marcelo E. Bigal;Sait Ashina;Rami Burstein

  • The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

    Michael J. Marmura;Stephen D. Silberstein;Todd J. Schwedt

  • Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

    Richard B Lipton;David W Dodick;Stephen D Silberstein;Joel R Saper

  • Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

    Joel R Saper;David W Dodick;Stephen D Silberstein;Sally McCarville

  • Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.

    David W. Dodick;Stephen D. Silberstein;Marcelo E. Bigal;Paul P. Yeung

  • The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

    Stephen D. Silberstein;J. Olesen;M. G. Bousser;H. C. Diener

Frequent Co-Authors

Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
David W. Dodick
David W. Dodick Mayo Clinic
Peter J. Goadsby
Peter J. Goadsby King's College London
Hans-Christoph Diener
Hans-Christoph Diener University of Duisburg-Essen
Stewart J. Tepper
Stewart J. Tepper Dartmouth College
Marcelo E. Bigal
Marcelo E. Bigal Albert Einstein College of Medicine
Messoud Ashina
Messoud Ashina University of Copenhagen
Rami Burstein
Rami Burstein Beth Israel Deaconess Medical Center
Shuu-Jiun Wang
Shuu-Jiun Wang National Yang Ming Chiao Tung University
Jes Olesen
Jes Olesen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA is not limited to traditional MD programs. Many prospective healthcare professionals are turning to flexible online degrees to accelerate their careers and specialize in high-demand fields. For nurses looking to advance their qualifications quickly, options like the 1 year dnp program online offer an efficient path to a Doctor of Nursing Practice degree.

Those seeking less rigorous commitments may prefer programs highlighted among the easiest online dnp programs, balancing work and study without compromising quality. For individuals aiming to enter the nursing field rapidly, 6 month lpn program options provide a fast track to licensure and employment.

Mental health remains a critical area in healthcare. If psychiatric care is your focus, consider specialized fast-track opportunities such as the fast track mental health nursing degrees. These online programs are designed to help you progress swiftly into fulfilling and in-demand medical roles, supporting both your career goals and the evolving needs of patients nationwide.

Best Scientists Citing Stephen D. Silberstein

Trending Scientists